On Friday, doctors at Massachusetts General Hospital announced that a 66-year-old New Hampshire man had successfully received ...

Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company harnessing the power of human genetics to ...

Though highly effective, medications for the prevention of chronic kidney disease progression are under-utilized, emphasizing the need for better use of prognostic tools.

For the second time in less than a year, doctors at Massachusetts General Hospital have transplanted a genetically-edited pig ...

For the second time in less than a year, doctors at Massachusetts General Hospital have transplanted a genetically-edited pig ...

A year after guidelines were revised to remove the use of race in eGFR, many labs and pathologists were still relying on the ...

Examples of selflessness are hard to find in today’s world.However, there are still some people in the world who think of ...

The Department of Health says dialysis eligibility in public facilities depends on kidney failure severity, life expectancy, and health complications.

ONE of the main diseases that lifestyle contributes to is diabetes which leads to kidney disease, says Dr Robin Sios.

The FDA will allow two biotechnology companies to run clinical trials: United Therapeutics and eGenesis. United Therapeutics ...

The US FDA has approved the first-ever clinical trials testing pig kidney transplants in people with kidney failure.

GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...